Merck Announces Second-Quarter 2026 Dividend

Core Points - Merck has declared a quarterly dividend of $0.85 per share for the second quarter of 2026, with payment scheduled for April 7, 2026, to shareholders of record as of March 16, 2026 [1] Company Overview - Merck, known as MSD outside the United States and Canada, has been dedicated to using leading-edge science to save and improve lives for over 130 years, focusing on the development of important medicines and vaccines [2] - The company aims to be the premier research-intensive biopharmaceutical company globally, leading in innovative health solutions for disease prevention and treatment in both humans and animals [2] - Merck promotes a diverse and inclusive workforce and operates responsibly to ensure a sustainable and healthy future for communities [2]